SOLUBLE INTERLEUKIN-33 RECEPTOR (sST-2)- A NOVEL MARKER FOR ASSESSING CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Patschan, S. [1 ]
Claus, I. [1 ]
Hoffmeister, M. [2 ]
Remus, C. [3 ]
Ritter, O. [3 ]
Patschan, D. [1 ]
机构：
[1] Brandenburg Med Sch Theodor Fontane, Dept Internal Med 1, Brandenburg, Germany
[2] Brandenburg Med Sch Theodor Fontane, Inst Biochem, Brandenburg, Germany
[3] Brandenburg Med Sch Theodor Fontane, Dept Internal Med 1, Brandenburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Disease-modifying Drugs (DMARDs); Biomarkers;
D O I：
10.1136/annrheumdis-2024-eular.4728
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0607
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-lnduced Septic Arthritis
    Staurengo-Ferrari, Larissa
    Trevelin, Silvia C.
    Fattori, Victor
    Nascimento, Daniele C.
    de Lima, Kalil A.
    Pelayo, Jacinta S.
    Figueiredo, Florencio
    Casagrande, Rubia
    Fukada, Sandra Y.
    Teixeira, Mauro M.
    Cunha, Thiago M.
    Liew, Foo Y.
    Oliveira, Rene D.
    Louzada-Junior, Paulo
    Cunha, Fernando Q.
    Alves-Filho, Jose C.
    Verri, Waldiceu A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [22] THE EFFECTS OF METHOTREXATE ON SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN RHEUMATOID-ARTHRITIS - COMMENT
    CRILLY, A
    MADHOK, R
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 597 - 598
  • [23] Predictive value of serum soluble interleukin-2 receptor levels in early rheumatoid arthritis
    Kuuliala, A
    Leirisalo-Repo, MA
    Möttönen, T
    Hannonen, P
    Nissilä, M
    Kautiainen, H
    Repo, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S438 - S439
  • [24] THE EFFECTS OF METHOTREXATE ON SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN RHEUMATOID-ARTHRITIS - REPLY
    BARRERA, P
    BOERBOOMS, AMT
    VANDEPUTTE, LBA
    VANDERMEER, JWM
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 598 - 599
  • [25] SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (SRAGE) AND RISK FOR CARDIOVASCULAR DISEASES IN FEMALES WITH RHEUMATOID ARTHRITIS
    Nadali, Mitra
    Bokarewa, Maria I.
    Silfversward, Sofia Toyra
    Erlandsson, Malin
    Lyngfelt, Lovisa
    Andersson, Karin Me
    Pullerits, Rille
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 691 - 691
  • [26] Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction
    ZHANG Kun
    ZHANG Xin-chao
    MI Yu-hong
    LIU Juan
    中华医学杂志（英文版）, 2013, 126 (19) : 3628 - 3631
  • [27] Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction
    Zhang Kun
    Zhang Xin-chao
    Mi Yu-hong
    Liu Juan
    CHINESE MEDICAL JOURNAL, 2013, 126 (19) : 3628 - 3631
  • [28] Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
    Takenaga, Keizo
    Akimoto, Miho
    Koshikawa, Nobuko
    Nagase, Hiroki
    PLOS ONE, 2020, 15 (04):
  • [29] Levels of soluble osteoclast-associated receptor (sOSCAR) in rheumatoid arthritis: link to disease severity and cardiovascular risk
    Ndongo-Thiam, Ndieme
    de Sallmard, Geoffroy
    Kastrup, Jesper
    Miossec, Pierre
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1276 - +
  • [30] INTERLEUKIN-2, SOLUBLE INTERLEUKIN-2 RECEPTOR AND TUMOR-NECROSIS-FACTOR IN SERA FROM PATIENTS WITH RHEUMATOID-ARTHRITIS
    CORVETTA, A
    LUCHETTI, MM
    POMPONIO, G
    DELLABITTA, R
    RECCHIONI, A
    STRUSI, P
    DESIO, G
    DANIELI, G
    RESEARCH IN CLINIC AND LABORATORY, 1990, 20 (04): : 275 - 281
12345